Language-population | Internal consistency | Construct validity | Concurrent validity | Agreement | Reliability | Responsiveness | Floor and ceiling effects | Discriminant validity | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total 0.82; Pain 0.65; Void 0.77; QOL 0.73 | Pain location 0.35–0.88 Pain frequency 0.18–0.87 Pain severity 0.39–0.95 Void 0.32–0.73 Impact 0.32–0.94 Overall QOL 0.35–0.94 | AUA symptom index: Pain 0.39; Void 0.87; QOL 0.46 GCPS Pain: Pain 0.61; Void 0.31; QOL 0.54; Total 0.60 GCPS Pain: Pain 0.38; Void 0.13; QOL 0.45; Total 0.40 | 0 | Pain 0.83–0.93; Void 0.90; QOL 0.87–0.91 | ROC curve 0.83 | % Ceiling Effects (best possible score) 20.70 Pain | CP/CPPS versus Healthy Individuals: 0.67 | |||||
Original-Australian [12] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Original-Malaysian [13] | Total 0.57; Pain 0.34; Void 0.32; QOL 0.33 | 0 | IPSS Total 0.63; Pain 0.23; Void 0.85; QOL 0.44 | Â | Total 0.89; Pain 0.89; Void 0.84; QOL 0.85 | 0 | 0 | CP/CPPS versus Healthy Individuals: Total 1.00; Pain 1.00; Void 0.87; QOL 1.00 CP/CPPS versus BPH: Total 0.; Pain 0.99; Void 0.39; QOL 0.75 | ||||
Original-Spanish [14] | Total 0.86; Pain 0.86; Void 0.79; QOL 0.87 | Total 0.89–0.97; Pain 0.80–0.97; Void 0.76–0.89; QOL 0.76–0.94 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Arabic-Egyptian [22] | Total 0.92; Pain 0.89; Void 0.92; QOL 0.87 | 0 | 0 | 0 | Total 0.90; Pain 0.84; Void 0.92; QOL 0.94 | 0 | 0 | Â | Â | CPPS | Controls | P |
Total | 22.3(4.1) | 2.3(2.8) |  < 0.001 | |||||||||
Pain | 9.3(2.5) | 0.6(0.2) |  < 0.001 | |||||||||
Void | 3.7(1.8) | 0.7(0.4) |  < 0.001 | |||||||||
QOL | 7.3(2.4) | 0.7(0.2) |  < 0.001 | |||||||||
Chinese-Mainland [23] | Total 0.61; Pain 0.71; Void 0.59; QOL 0.75 | 0 | 0 | 0 | Total 0.98; Pain 0.98; Void 0.98; QOL 0.97 | 0 | 0 | Â | Â | CPPS | Controls | P |
Total | 23.33(5.91) | 1.95(1.97) | 0.00 | |||||||||
Pain | 8.80(4.26) | 0.37(1.03) | 0.00 | |||||||||
Void | 5.30(2.82) | 0.15(0.58) | 0.00 | |||||||||
QOL | 9.23(1.90) | 1.42(1.20) | 0.00 | |||||||||
Chinese-Malaysian [13] | Total 0.63; Pain 0.33; Void 0.73; QOL 0.60 | 0 | IPSS Total 0.72; Pain 0.35; Void 0.78; QOL 0.29 | 0 | Total 0.9; Pain 0.80; Void 0.82; QOL 0.77 | 0 | 0 | CP/CPPS versus Healthy Individuals: Total 1.00; Pain 1.00; Void 0.90; QOL 0.99 CP/CPPS versus BPH: Total 0.87; Pain 0.96; Void 0.47; QOL 0.68 | ||||
Danish [24] | 0 | 0 | 0 | No signs of systematic bias in Bland Altman Plot | Total 0.93 (0.91–0.96); Pain 0.88 (0.84–0.92); Void 0.91 (0.88–0.94); QOL 0.93 (0.91–0.96) | 0 | 0 | 0 | ||||
Estonian [25] | Total 0.82; Pain 0.67; Void 0.63; QOL 0.78 | Total 0.62–0.93; Pain 0.35–0.92; Void 0.35–0.62; QOL 0.47–0.93 | 0 | 0 | 0 | 0 | 0 |  |  | CPPS | Controls | P |
Total | 15.3 (5.6) | 6.0 (6.7) |  < 0.001 | |||||||||
Pain | 8.6 (2.5) | 2.2 (3.3) |  < 0.001 | |||||||||
Void | 1.2(1.4) | 1.3 (1.9) | 0.86 | |||||||||
QOL | 6.1 (2.1) | 2.5(3.0) | 0.001 | |||||||||
Finnish [26] | 0 | Pain 0.36–0.89; Void 0.36–0.67; QOL 041–0.71 | VAS Total 0.76; Pain 0.87; Void 0.27; QOL 0.60 | 0 | 0 | 0 | 0 |  |  | CPPS | Controls | P |
Total | 20.2 (8.6) | 5.8 (4.5) |  < 0.001 | |||||||||
Pain | 9.9 (4.5) | 0.1 (0.3) |  < 0.001 | |||||||||
Void | 3.9 (3.1) | 0.3 (0.6) |  < 0.001 | |||||||||
QOL | 6.5 (2.9) | 5.5 (4.3) |  > 0.05 | |||||||||
French-Canadian [27] | Pain 0.807; Void 0.570; QOL 0.884 | Pain 0.67–0.94; Void 0.55–0.67; QOL 0.62–0.0.97 | SF− 12 Mental scale Pain − 0.29 to − 0.44; Void − 0.28 to − 0.43; QOL − 0.41 to − 0.51 SF− 12 Mental scale Pain − 0.32 to − 0.50; Void − 0.20 to − 0.37; QOL − 0.40 to − 0.59 | 0 | 0.352–0.862 | 0 | 0 |  |  | CPPS | Controls | P |
Pain | 8.48 (4.67) | 1.72 (2.27) |  < 0.001 | |||||||||
Void | 3.33 (2.31) | 0.95 (1.12) |  < 0.001 | |||||||||
QOL | 5.39 (2.84) | 0.76 (1.81) |  > 0.05 | |||||||||
Total 0.74; Pain 0.60; Void 0.69; QOL 0.67 | Total 0.63–0.85 Pain 0.24–0.85; Void 0.24–0.63; QOL 0.32–0.77 | 0 | 0 | 0 | 0 | 0 |  |  | NIH IIIA | NIH IIIB | P | |
Total | 20(21.4) | 24(23.9) | 0.03 | |||||||||
Pain | 11(10.1) | 12(11.3) | 0.09 | |||||||||
Void | 3(3.2) | 3(3.8) | 0.14 | |||||||||
QOL | 8(8) | 9(8.7) | 0.16 | |||||||||
Italian [30] | Total 0.95; Pain 0.84; Void 0.96; QOL 0.86 | 0 | VAS Total 0.80; Pain 0.88; Void 0.22; QOL 0.71 IPSS Total 0.55; Pain 0.27; Void 0.94; QOL 0.25 | 0 | Total 0.90; Pain 0.83; Void 0.82; QOL 0.93 | 0 | 0 | Â | Â | CPPS | Controls | P |
Total | 21.8 (8.5) | 2.0 (2.8) |  < 0.001 | |||||||||
Pain | 10.5 (4.5) | 0.5 (1.2) |  < 0.001 | |||||||||
Void | 4.5 (2.9) | 0.9 (1.2) |  < 0.001 | |||||||||
QOL | 6.8 (3.1) | 0.6 (1.0) |  < 0.001 | |||||||||
Japanese (a) [31] | 0 | Pain 0.662; Void 0.531 | 0 | 0 | 0 | 0 | 0 | Â | CP/CPPS | BPH | Controls | P |
Pain | 9.79 (3.10) | 1.66 (3.05) | 0.39 (0.92) | 0.00 | ||||||||
Void | 3.82 (3.12) | 3.29 (2.08) | 0.72 (0.83) | 0.00 | ||||||||
QOL | 8.21 (2.23) | 4.17 (1.86) | 1.39 (1.38) | 0.00 | ||||||||
Japanese (b) [32] | Pain 0.83; Void 0.97; QOL 0.87 | 0 | 0 | 0 | Pain 0.63; Urinary symptoms 0.91; QOL 0.72 | 0 | 0 | Â | CP | BPH | Controls | P |
Pain | 9.0 (0–18) | 1.0 (− 16) | 0.0 (0–12) | 0.00 | ||||||||
Void | 3.0 (0–10) | 4.0 (0–10) | 0.0 (0–8) | 0.00 | ||||||||
QOL | 7.0 (2–11) | 5.0 (0–12) | 1.0 (0–6) | 0.00 | ||||||||
Malaysian [13] | Total 0.62; Pain 0.43; Void 0.83; QOL 0.45 | 0 | IPSS Total 0.49; Pain − 0.18; Void 0.87; QOL 0.16 | 0 | Total 0.80; Pain 0.94; Urinary symptoms 0.87; QOL 0.85 | 0 | 0 | CP/CPPS versus Healthy Individuals: Total 1.00; Pain 1.00; Void 0.83; QOL 0.98 | ||||
CP/CPPS versus BPH: Total 0.94; Pain 0.96; Void 0.58; QOL 0.78 | ||||||||||||
Persian [33] | Total 0.865; Pain 0.853; Void 0.652; QOL 0.726 | Total 0.666–0.889; Pain 0.389–0.889; Void 0.389–0.666; QOL 0.433–0.846 | 0 | 0 | Total 0.901; Pain 0.894; Void 0.912; QOL 0.846 | 0 | 0 |  |  | CP/CPPS | Controls | P |
 | Total | 22.47(6.9) | 2.1(2.7) |  < 0.001 | ||||||||
 | Pain | 10.35(3.7) | 0.3(0.2) |  < 0.001 | ||||||||
 | Void | 4.73(1.98) | 0.5(0.4) |  < 0.001 | ||||||||
 | QOL | 7.38(2.7) | 0.8(0.4) |  < 0.001 | ||||||||
Portuguese-Brazilian [34] | Pain 0.90; Void 0.85; QOL 0.93 | 0 | 0 | 0 | Pain 0.89–0.94; Void 0.99; QOL 0.96–0.97 | 0 | 0 | / | ||||
Spanish [14] | Total 0.94; Pain 0.87; Void 0.81; QOL 0.86 | Total 0.89–0.97; Pain 0.80–0.97; Void 0.76–0.89; QOL 0.76–0.94 | 0 | 0 | 0 | 0 | 0 | / | ||||
Turkish [35] | Total 0.864; Pain 0.862; Void 0.819; QOL 0.762 | Total 0.66–0.77; Pain 0.25–0.72; Void 0.33–0.72; QOL 0.25–0.66 | VAS Total 0.6; Pain 0.66; Void 0.22; QOL 0.29 | 0 | Total 0.909; Pain 0.886; Void 0.925; QOL 0.874 | IPSS Total 0.48; Pain 0.24; Void 0.54; QOL 0.4 | 0 | 0 |  | CP/CPPS | Controls | P |
Total | 22.8 (7.7) | 2.5 (1.7) |  < 0.001 | |||||||||
Pain | 9.5 (4.8) | 1.4 (1.2) |  < 0.001 | |||||||||
Void | 6 (3.2) | 0.6 (0.8) |  < 0.001 | |||||||||
QOL | 7.3 (2.3) | 0.5 (0.6) |  < 0.001 |